Gamma-Retrovirus integration marks cell type-specific cancer genes: A novel profiling tool in cancer genomics

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Gilroy, Kathryn L ^a   Terry, Anne ^a   Naseer, Asif ^a,d   De Ridder, Jeroen ^b   Allahyar, Amin ^b   Wang, Weiwei ^c   Carpenter, Eric ^c   Mason, Andrew ^c   Wong, Gane K S ^c   Cameron, Ewan R ^a   Kilbey, Anna ^a   Neil, James C ^a  

^a MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c UNIVERSITY OF ALBERTA   (Canada)

^d KHYBER MEDICAL UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; LONG UNTRANSLATED RNA; PROTEIN MALAT1; UNCLASSIFIED DRUG; CHROMATIN;

ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CARCINOGENICITY; CELL SPECIFICITY; CHROMATIN; CONTROLLED STUDY; FELINE LEUKEMIA VIRUS; GAMMARETROVIRUS; GAMMARETROVIRUS INTEGRATION PROFILING; GENETIC PROCEDURES; GENOMICS; HUMAN; HUMAN CELL; MCF 7 CELL LINE; NEOPLASM; NONHUMAN; TUMOR GENE; VIROGENESIS; VIRUS DNA CELL DNA INTERACTION; ANIMAL; CAT; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; MCF-7 CELL LINE; RETROVIRUS INFECTION; TRANSCRIPTION INITIATION SITE; TUMOR CELL LINE; VIROLOGY; VIRUS INFECTION;

ANIMALS; CATS; CELL LINE, TUMOR; CHROMATIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; LEUKEMIA VIRUS, FELINE; MCF-7 CELLS; NEOPLASMS; RETROVIRIDAE INFECTIONS; TRANSCRIPTION INITIATION SITE; TUMOR VIRUS INFECTIONS; VIRUS INTEGRATION;

EID: 84978999427     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154070     Document Type: Article

References (42)

1. Uren AG, Kool J, Berns A, van LM. Retroviral insertional mutagenesis: past, present and future. Oncogene 2005; 24: 7656-7672. 1209043 [pii];doi: 10.1038/sj.onc.1209043 PMID: 16299527
2. Hanlon L, Barr NI, Blyth K, Stewart M, Haviernik P, Wolff L et al. Long-range effects of retroviral insertion on c-myb: overexpression may be obscured by silencing during tumor growth in vitro. J Virol 2003; 77: 1059-1068. PMID: 12502821
3. Hacein-Bey-Abina S, von KC, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415-419. doi: 10.1126/science.1088547;302/5644/415 [pii]. PMID: 14564000
4. Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 2008; 118: 3143-3150. doi: 10.1172/JCI35798 PMID: 18688286
5. Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, Naiman DQ et al. New genes involved in cancer identified by retroviral tagging. Nat Genet 2002; 32: 166-174. doi: 10.1038/ng949;ng949 [pii]. PMID: 12185365
6. Mikkers H, Allen J, Knipscheer P, Romeijn L, Hart A, Vink E et al. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet 2002; 32: 153-159. doi: 10. 1038/ng950;ng950 [pii]. PMID: 12185366
7. Hwang HC, Martins CP, Bronkhorst Y, Randel E, Berns A, Fero M et al. Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis. Proc Natl Acad Sci U S A 2002; 99: 11293-11298. doi: 10.1073/pnas.162356099;162356099 [pii]. PMID: 12151601
8. Maertens G, Cherepanov P, Pluymers W, Busschots K, De CE, Debyser Z et al. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 2003; 278: 33528-33539. doi: 10.1074/jbc.M303594200;M303594200 [pii]. PMID: 12796494
9. Cherepanov P, Maertens G, Proost P, Devreese B, Van BJ, Engelborghs Y et al. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem 2003; 278: 372-381. doi: 10.1074/jbc.M209278200;M209278200 [pii]. PMID: 12407101
10. Fan H. Leukemogenesis by Moloney murine leukemia virus: a multistep process. Trends Microbiol 1997; 5: 74-82. S0966-842X(96)10076-7 [pii];doi: 10.1016/S0966-842X(96)10076-7 PMID: 9108934
11. Tsatsanis C, Fulton R, Nishigaki K, Tsujimoto H, Levy L, Terry A et al. Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement. J Virol 1994; 68: 8296-8303. PMID: 7966623
12. Wu X, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003; 300: 1749-1751. doi: 10.1126/science.1083413;300/5626/1749 [pii]. PMID: 12805549
13. Gupta SS, Maetzig T, Maertens GN, Sharif A, Rothe M, Weidner-Glunde M et al. Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration. J Virol 2013; 87: 12721-12736. JVI.01942-13 [pii];doi: 10.1128/JVI.01942-13 PMID: 24049186
14. Sharma A, Larue RC, Plumb MR, Malani N, Male F, Slaughter A et al. BET proteins promote efficient murine leukemia virus integration at transcription start sites. Proc Natl Acad Sci U S A 2013; 110: 12036-12041. 1307157110 [pii];doi: 10.1073/pnas.1307157110 PMID: 23818621
15. De Rijck J., de K C, Demeulemeester J, Vets S, El A S, Malani N et al. The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites. Cell Rep 2013; 5: 886-894. S2211-1247(13)00563-9 [pii];doi: 10.1016/j.celrep.2013.09.040 PMID: 24183673
16. Zhao Y, Yang CY, Wang S. The making of I-BET762, a BET bromodomain inhibitor now in clinical development. J Med Chem 2013; 56: 7498-7500. doi: 10.1021/jm4014407 PMID: 24107192
17. Cattoglio C, Pellin D, Rizzi E, Maruggi G, Corti G, Miselli F et al. High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors. Blood 2010; 116: 5507-5517. blood-2010-05-283523 [pii];doi: 10.1182/blood-2010-05-283523 PMID: 20864581
18. LaFave MC, Varshney GK, Gildea DE, Wolfsberg TG, Baxevanis AD, Burgess SM. MLV integration site selection is driven by strong enhancers and active promoters. Nucleic Acids Res 2014; 42: 4257-4269. gkt1399 [pii];doi: 10.1093/nar/gkt1399 PMID: 24464997
19. Jarrett O, Laird HM, Hay D. Growth of feline leukaemia virus in human cells. Nature 1969; 224: 1208-1209. PMID: 5358345
20. Sugai J, Eiden M, Anderson MM, Van HN, Meiering CD, Overbaugh J. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2. J Virol 2001; 75: 6841-6849. doi: 10.1128/JVI.75.15.6841-6849.2001 PMID: 11435563
21. Aiyer S, Swapna GV, Malani N, Aramini JM, Schneider WM, Plumb MR et al. Altering murine leukemia virus integration through disruption of the integrase and BET protein family interaction. Nucleic Acids Res 2014; 42: 5917-5928. gku175 [pii];doi: 10.1093/nar/gku175 PMID: 24623816
22. Huser CA, Gilroy KL, de RJ, Kilbey A, Borland G, Mackay N et al. Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc/p53-dependent bottleneck in lymphomagenesis. PLoS Genet 2014; 10: e1004167. doi: 10.1371/journal.pgen.1004167;PGENETICS-D-13-02644 [pii]. PMID: 24586197
23. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R et al. A census of human cancer genes. Nat Rev Cancer 2004; 4: 177-183. doi: 10.1038/nrc1299;nrc1299 [pii]. PMID: 14993899
24. Naseer A, Terry A, Gilroy K, Kilbey A, Watts C, Mackay N et al. Frequent infection of human cancer xenografts with murine endogenous retroviruses in vivo. Viruses 2015; 7: 2014-2029. v7042014 [pii]; doi: 10.3390/v7042014 PMID: 25912714
25. Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013; 153: 307-319. S0092-8674(13)00392-9 [pii];doi: 10.1016/j.cell.2013.03.035 PMID: 23582322
26. Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013; 153: 320-334. S0092-8674(13)00393-0 [pii];doi: 10.1016/ j.cell.2013.03.036 PMID: 23582323
27. Chapuy B, McKeown MR, Lin CY, Monti S, Roemer MG, Qi J et al. Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell 2013; 24: 777-790. S1535-6108(13)00491-1 [pii];doi: 10.1016/j.ccr.2013.11.003 PMID: 24332044
28. Khan A, Zhang X. dbSUPER: a database of super-enhancers in mouse and human genome. Nucleic Acids Res 2016; 44(D1): D164-71. doi: 10.1093/nar/gkv1002 PMID: 26438538
29. Pott S, Lieb JD. What are super-enhancers? Nat Genet 2015; 47: 8-12. ng.3167 [pii];doi: 10.1038/ng.3167. PMID: 25547603
30. Kool J, Uren AG, Martins CP, Sie D, de Ridder J., Turner G et al. Insertional mutagenesis in mice deficient for p15Ink4b, p16Ink4a, p21Cip1, and p27Kip1 reveals cancer gene interactions and correlations with tumor phenotypes. Cancer Res 2010; 70: 520-531. 0008-5472.CAN-09-2736 [pii];doi: 10.1158/ 0008-5472.CAN-09-2736 PMID: 20068150
31. Levine M, Cattoglio C, Tjian R. Looping back to leap forward: transcription enters a new era. Cell 2014; 157: 13-25. S0092-8674(14)00201-3 [pii];doi: 10.1016/j.cell.2014.02.009 PMID: 24679523
32. Davie K, Jacobs J, Atkins M, Potier D, Christiaens V, Halder G et al. Discovery of transcription factors and regulatory regions driving in vivo tumor development by ATAC-seq and FAIRE-seq open chromatin profiling. PLoS Genet 2015; 11: e1004994. doi: 10.1371/journal.pgen.1004994;PGENETICS-D-14-02754 [pii]. PMID: 25679813
33. Simon JM, Giresi PG, Davis IJ, Lieb JD. Using formaldehyde-assisted isolation of regulatory elements (FAIRE) to isolate active regulatory DNA. Nat Protoc 2012; 7: 256-267. nprot.2011.444 [pii];doi: 10. 1038/nprot.2011.444 PMID: 22262007
34. Yoshimoto R, Mayeda A, Yoshida M, Nakagawa S. MALAT1 long non-coding RNA in cancer. Biochim Biophys Acta 2016; 1859(1): 192-9. S1874-9399(15)00206-0 [pii];doi: 10.1016/j.bbagrm.2015.09.012PMID: 26434412
35. Zhang B, Arun G, Mao YS, Lazar Z, Hung G, Bhattacharjee G et al. The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep 2012; 2: 111-123. S2211-1247(12)00163-5 [pii];doi: 10.1016/j.celrep.2012.06.003 PMID: 22840402
36. Mattison J, Kool J, Uren AG, de Ridder J., Wessels L, Jonkers J et al. Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach. Cancer Res 2010; 70: 883-895. 0008-5472.CAN-09-1737 [pii];doi: 10.1158/0008-5472.CAN-09-1737 PMID: 20103622
37. Sorensen KD, Kunder S, Quintanilla-Martinez L, Sorensen J, Schmidt J, Pedersen FS. Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage. Virology 2007; 362: 179-191. S0042-6822(06)00897-X [pii];doi: 10.1016/j.virol.2006.12.016 PMID: 17258785
38. Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A, Morillon E et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 2008; 118: 3132-3142.doi: 10.1172/JCI35700 PMID: 18688285
39. Braun CJ, Boztug K, Paruzynski A, Witzel M, Schwarzer A, Rother M et al. Gene therapy for Wiskott-Aldrich syndrome-long-term efficicy and genotoxicity. Sci Transl Med 2014; 6: 227ra33. doi: 10.1126/ scitranslmed.3007280 PMID: 24622513
40. Wang W, Indik S, Wasilenko ST, Faschinger A, Carpenter EJ, Tian Z et al. Frequent proviral integration of the human betaretrovirus in biliary epithelium of patients with autoimmune and idiopathic liver disease. Aliment Pharmacol Ther 2015; 41: 393-405. doi: 10.1111/apt.13054 PMID: 25521721
41. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003; 100: 9440-9445. doi: 10.1073/pnas.1530509100;1530509100 [pii]. PMID: 12883005
42. ZhuL.J. GazinC. LawsonN.D. PagesH. LinS.M. LapointeD.S.et alChIPpeakAnno: A Bioconductor package to annotate ChIP-seq and ChIP-chip dataBMC Bioinformatics2010112371471-2105-11-237 PMID: 2045980410.1186/1471-2105-11-237